核子醫學影像設備市場：規模、佔有率、法規、報銷、安裝單位以及 2036 年各細分市場預測

核子醫學設備使用放射性物質（也稱為核子醫學或放射性藥物），透過口服或靜脈注射到體內。這些系統捕捉放射性藥物發射的輻射並創建身體內部結構和活動的圖像。這些影像使醫生能夠看到人體內部，找出疾病或損傷的原因，並做出準確的診斷。

核子醫學影像是一種非侵入性醫療技術，使用放射性追蹤劑（例如F-18氟脫氧葡萄糖）來評估和診斷各種身體功能和疾病，包括癌症、心臟、胃腸道、內分泌和神經系統疾病。核子醫學影像設備分為正子斷層掃瞄 (PET) 系統和單光子發射電腦斷層掃瞄 (SPECT) 系統。這些系統的進階版包括 PET/CT、PET/MRI、SPECT/CT 和 SPECT/MRI，結合了 PET 和 CT/MRI 或 SPECT 和 CT/MRI 功能。

本報告對全球核子醫學影像設備市場進行了詳細分析，包括競爭格局、SWOT 分析、2015 年至 2036 年各細分市場的年度總銷售額和市場預測、以及各地區和國家的趨勢。

目錄

目前核醫學影像設備的市場現況及競爭格局

• 洞察關鍵產業趨勢
• 2015 年至 2036 年核醫影像設備各細分市場總收入及市場預測
• 有關單位、平均售價和市場價值的詳細數據

全球、區域和國家見解

• 核子醫學影像設備市場的 SWOT 分析
• 深入瞭解核醫影像設備市場的競爭動態與趨勢
• 按國家/地區劃分的醫療保健系統概覽
• 各國報銷政策
• 各國醫療技術法規現狀

Nuclear Imaging Equipment Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Diagnostic Imaging therapeutic area.

Nuclear medicine equipment makes use of radioactive substances (also called as nuclear medicine or radiopharmaceuticals) that are inserted into the body orally or intravenously. These systems capture the radiations emitted by radiopharmaceuticals to create images of the structures and activities inside the human body. These images enable physicians to look inside a human body to help determine the cause of an illness or injury and provide an accurate diagnosis.

Nuclear Imaging is a non-invasive medical technique that uses radioactive tracers, such as F-18 Fluorodeoxyglucose, to evaluate and diagnose various bodily functions and diseases, including cancers, cardiac, gastrointestinal, endocrine, and neurological conditions. Nuclear Imaging Equipment's have been classified into Positron Emission Tomography (PET) Systems and Single Photon Emission Computed Tomography (SPECT) Systems. The advanced version of these systems include PET/CT, PET/MRI, SPECT/CT and SPECT/MRI, incorporating features from both PET and CT/MRI or SPECT and CT/MRI.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Nuclear Imaging Equipment and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Nuclear Imaging Equipment market revenue by segment and market outlooks from 2015-2036.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Nuclear Imaging Equipment market.
• Competitive dynamics insights and trends provided for Nuclear Imaging Equipment market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: GE HealthCare Technologies Inc, Siemens Healthineers AG, Shanghai United Imaging Healthcare Co Ltd, Canon Medical Systems Corp and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Nuclear Imaging Equipment marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Nuclear Imaging Equipment market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Nuclear Imaging Equipment market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Nuclear Imaging Equipment market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.